Sage Therapeutics craters 64% after failing a key trial for its depression drug - Business Insider

Submitted by Anonymous (not verified) on Thu, 12/05/2019 - 13:57

Sage Therapeutics craters 64% after failing a key trial for its depression drug  Business Insider